SaltX Technology Holding B Logo

SaltX Technology Holding B

Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.

SALT | ST

Overview

Corporate Details

ISIN(s):
SE0005308541 (+1 more)
LEI:
549300W31010S0FY9U64
Country:
Sweden
Address:
Västertorpsvägen 135, 129 44 Hägersten
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SaltX Technology is a greentech company dedicated to decarbonizing heavy industries and eliminating their dependency on fossil fuels. The company innovates and industrializes electrification and carbon separation technologies targeting hard-to-abate sectors like cement and quicklime. Its core technology is the Electric Arc Calciner (EAC), a proprietary electric calcination process that replaces fossil-fuel heating. The EAC technology simultaneously separates and captures process-related CO2 emissions, creating a pathway to zero-emission manufacturing. SaltX collaborates with major industrial partners, such as Holcim and SMA Mineral, to scale its solutions and achieve gigaton-level impact on global emissions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SaltX Technology Holding B filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SaltX Technology Holding B

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SaltX Technology Holding B via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG

Talk to a Data Expert

Have a question? We'll get back to you promptly.